Literature DB >> 15888975

Pleomorphic carcinoma of the lung associated with loss of heterozygosity of p53 gene.

Norimasa Arita1, Yoshiki Mikami, Minako Yoshida, Ichiro Konishi, Norio Horiike, Katsutoshi Miyauchi, Tatsuhiko Miyazaki, Masato Nose, Masao Ono.   

Abstract

We report a case with pleomorphic carcinoma of the lung in a 70-year-old man. Pleomorphic carcinoma is characterized by a heterogenous composition that includes epithelial and mesechymal malignancies. In the present case, the tumor was composed of a mixture of unequivocal squamous cell carcinoma and spindle cell components resembling sarcomatous overgrowth. The spindle component did not include a heterologous mesenchymal element characterized by overt differentiation for bone, cartilage, neuron or muscle tissue. To evaluate a state of differentiation of the spindle cell component, we immunohistochemically examined expression of the antigens including vimentin, cytokeratin, sarcomeric actin, alpha-smooth muscle actin, S-100 protein, CD34, Factor VIII, and CD68. The results showed sole expression of vimentin in the spindle cell component, suggesting an immature state of the mesenchymal lineage. Furthermore, the spindle cell component of this case was genetically characterized by loss of heterozygosity (LOH) at a codon 234 of exon 7 of the p53 gene. This mutation causes an amino-acid replacement (Tyr to Cys), which was previously proven to attenuate p53 function. The present case may suggest a relation between somatic alteration of the p53 gene and histogenesis of pleomorphic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888975     DOI: 10.1620/tjem.206.181

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Pleomorphic carcinoma of the lung arising in a patient with Li-Fraumeni syndrome: report of a case.

Authors:  Tatsuya Kato; Keidai Ishikawa; Masaaki Satoh; Satoshi Kondo; Mitsuhito Kaji
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

2.  Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.

Authors:  Soohyeon Lee; Youngwook Kim; Jong-Mu Sun; Yoon La Choi; Jhin Gook Kim; Young-Mog Shim; Yeon Hee Park; Jin Seok Ahn; Keunchil Park; Jung Ho Han; Myung-Ju Ahn
Journal:  J Cancer Res Clin Oncol       Date:  2011-05-28       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.